BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21816293)

  • 1. Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy: in regard to Georg et al. (Int J Radiat Oncol Biol Phys 2011;79:356-362).
    Shi M; Wei L
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):315; author reply 315-6. PubMed ID: 21816293
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy.
    Georg P; Lang S; Dimopoulos JC; Dörr W; Sturdza AE; Berger D; Georg D; Kirisits C; Pötter R
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):356-62. PubMed ID: 20385450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy.
    Georg P; Pötter R; Georg D; Lang S; Dimopoulos JC; Sturdza AE; Berger D; Kirisits C; Dörr W
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):653-7. PubMed ID: 21345618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160-1172).
    Pötter R; Dimopoulos J; Kirisits C; Lang S; Haie-Meder C; Briot E; Dumas I; Van Limbergen E; De Brabandere M; Nulens A; Erickson B; Rownd J; Petrow P
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):293-5; author reply 295-6. PubMed ID: 15850940
    [No Abstract]   [Full Text] [Related]  

  • 5. In regard to correspondence between Pötter et al. and Nag et al. (Int J Radiat Oncol Biol Phys 2005;62:293-295).
    Narayan K; vanDyk S; Bernshaw DL
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):644-5; author reply 645-7. PubMed ID: 16168857
    [No Abstract]   [Full Text] [Related]  

  • 6. Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer.
    Fenkell L; Assenholt M; Nielsen SK; Haie-Meder C; Pötter R; Lindegaard J; Tanderup K
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1572-9. PubMed ID: 20800373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. In regard to Kidd et al. (Int J Radiat Oncol Biol Phys 2010;77:1085-1091.).
    Wei L; Shi M
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):636-7; author reply 637. PubMed ID: 20980107
    [No Abstract]   [Full Text] [Related]  

  • 8. Minimizing urinary bladder radiation dose during brachytherapy for carcinoma of the cervix using balloon inflation technique: In regard to Malaker et al. (Int J Radiat Oncol Biol Phys 2005;61:257-266).
    Luh JY; Eng TY; Fuller CD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):944; author reply 944-5. PubMed ID: 15936589
    [No Abstract]   [Full Text] [Related]  

  • 9. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
    Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on "computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachtherapy: results of a prospective trial and preliminary guidelines for standardized contours" by Viswanathan et Al. (Int j radiat oncol biol phys 2007;68:491-498, 2007).
    Cengiz M; Yildiz F; Selek U; Ozyigit G
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):963; author rply 963-4. PubMed ID: 17889281
    [No Abstract]   [Full Text] [Related]  

  • 11. [Locally advanced cervical cancer: Should intensity-modulated radiotherapy replace brachytherapy?].
    Mazeron R; Gilmore J; Khodari W; Dumas I; Haie-Méder C
    Cancer Radiother; 2011 Oct; 15(6-7):477-83. PubMed ID: 21880534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity-modulated brachytherapy or EBRT for prostate cancer patients: in regard to Prada et al. (Int J Radiat Oncol Biol Phys 2007;69:95-102.).
    Vordermark D; Guckenberger M; Baier K; Markert K
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):316-7. PubMed ID: 18406899
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor heterogeneity of FIGO Stage III carcinoma of the uterine cervix: in regard to Kim et al. (Int J Radiation Oncology Biol Phys 2009;75:1323-1328).
    Chen SW; Liang JA
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1605-6; author reply 1606-7. PubMed ID: 20637983
    [No Abstract]   [Full Text] [Related]  

  • 14. Intermediate dose-volume parameters and the development of late rectal toxicity after MRI-guided brachytherapy for locally advanced cervix cancer.
    Ujaimi R; Milosevic M; Fyles A; Beiki-Ardakani A; Carlone M; Jiang H; Lindsay P; Xie J; Gerber R; Croke J; Skliarenko J; Levin W; Han K
    Brachytherapy; 2017; 16(5):968-975.e2. PubMed ID: 28757404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
    Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late side effects of 3T MRI-guided 3D high-dose rate brachytherapy of cervical cancer : Institutional experiences.
    Vojtíšek R; Sukovská E; Baxa J; Budíková M; Kovářová P; Fínek J
    Strahlenther Onkol; 2019 Nov; 195(11):972-981. PubMed ID: 31309266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy in pleural malignant mesothelioma: why not! In regard to Scorsetti et al. (Int J Radiat Oncol Biol Phys 2010;77:942-949); Krayenbuehl et al. (Int J Radiat Oncol Biol Phys 2010;78:628-634).
    Russi EG; Numico G; Ricardi U
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1279; author reply 1279-80. PubMed ID: 21353165
    [No Abstract]   [Full Text] [Related]  

  • 18. In regard to Fiorino et al.: Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:953-962).
    Bauman G; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):912-4; author reply 914-5. PubMed ID: 15183497
    [No Abstract]   [Full Text] [Related]  

  • 19. In regard to Chen et Al. (Int J Radiat Oncol Biol Phys 2007;69:25-31) and Chao et Al. (Int j Radiat Oncol Biol Phys 2007;69:32-40).
    Yaeger TE
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):317; author reply 317-8. PubMed ID: 18406902
    [No Abstract]   [Full Text] [Related]  

  • 20. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
    Chargari C; Magné N; Dumas I; Messai T; Vicenzi L; Gillion N; Morice P; Haie-Meder C
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):133-9. PubMed ID: 18774656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.